Updated just now · Live
Stock analysis, price data, and AI-powered insights for GoodRx Holdings Inc (GDRX).
GoodRx Holdings Inc operates in the Health Care sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for GDRX.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). GDRX Stock Intelligence Report. [stoxpulse.com/stocks/gdrx]
Disclaimer: The information on this page about GoodRx Holdings Inc (GDRX) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for GoodRx Holdings Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
GoodRx Announces Date for First Quarter 2026 Earni...
1d ago
GoodRx Rallies As Wegovy HD Rollout Targets Self-P...
6d ago
StoxPulse AI results for GDRX: Pulse Score 45/100. Primary sentiment trends from 4 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$811.9M
P/E Ratio
—
EPS
—
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call
GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market
GoodRx Says New Higher Dose Wegovy HD Injection 7.2 Mg Is Now Available To Eligible Self-Pay Patients On GoodRx At $399 Per Month
GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price